title: Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children?
authors.forename: M
authors.initials: M
authors.lastname: Piskunowicz
authors.forename: W
authors.initials: W
authors.lastname: Kosiak
authors.forename: N
authors.initials: N
authors.lastname: Irga
mesh_terms: D000328:Adult; D000418:Albumins / Q000009:adverse effects; D002648:Child; D003287:Contrast Media / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D017041:Ethics Committees; D005060:Europe; D005466:Fluorocarbons / Q000009:adverse effects; D006625:Hippocratic Oath; D006801:Humans; D010743:Phospholipids / Q000009:adverse effects; D013459:Sulfur Hexafluoride / Q000009:adverse effects; D014463:Ultrasonography / Q000941:ethics*; D014481:United States
chemical_list: D000418:Albumins; D003287:Contrast Media; C099458:FS 069; D005466:Fluorocarbons; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride; C042852:perflutren